Update Your Profile Member Spotlights Refer a Member: IASP Champions Join a Special Interest Group (SIG) Find a Chapter Join Now
PAIN PAIN Reports Pain Research Forum Papers of the Week Webinars and Podcasts Events
Online Learning - PERC Webinars & Podcasts Curricula Graduate Opportunities Events
RELIEF News Resources for Living with Pain Global Alliance of Partners in Pain Advocacy (GAPPA) Events
Support IASP Sponsor an Event Become a Partner
< BACK TO ARCHIVE
POW ARCHIVE WEEK: Papers: 1 Feb 2020 - 7 Feb 2020
STUDY TYPE:Pharmacology/Drug Development
PAIN TYPE:Migraine/Headache
DATE PUBLISHED: 2021 Jul
JOURNAL:J Neurol
PUBMED: http://www.ncbi.nlm.nih.gov/pubmed/32006159?dopt=Abstract
Volume:268
ISSUE:7
This meta-analysis aimed to systematically evaluate the effectiveness and safety of galcanezumab in the prophylactic treatment of adult migraine.
